A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus | MicrobiomeTrials
A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
RecruitingPHASE3INTERVENTIONAL
Trial Details
Start: 2026-08-24Est. Completion: 2028-08-09
Enrollment target: 500 participants
Locations
Research Site, Escondido, California, United States
Research Site, Lincoln, California, United States
Research Site, Walnut Creek, California, United States
Research Site, Fleming Island, Florida, United States
Research Site, Jacksonville, Florida, United States
Research Site, Stockbridge, Georgia, United States
Research Site, Woodstock, Georgia, United States
Research Site, Champaign, Illinois, United States
Research Site, Chicago, Illinois, United States
Research Site, Beltsville, Maryland, United States
Research Site, Oxon Hill, Maryland, United States
Research Site, Kansas City, Missouri, United States
Research Site, Las Vegas, Nevada, United States
Research Site, Somerset, New Jersey, United States
Research Site, Statesville, North Carolina, United States
Research Site, Fargo, North Dakota, United States
Research Site, Columbus, Ohio, United States
Research Site, Portland, Oregon, United States
Other microbiome trials you might be interested in